SCHEMBL25429273

SCHEMBL25429273

O=C(O)NCCCn1ccc(=O)c2ccc(-c3ccccc3Oc3ccc(C(F)(F)F)cc3)cc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOD2 Q9HC29 3/20 0.37
▸ NOD1 Q9Y239 3/20 0.37
▸ EGLN1 Q9GZT9 2/20 0.37
▸ TRPV1 Q8NER1 1/20 0.36
▸ SCN8A Q9UQD0 1/20 0.36
▸ SCN10A Q9Y5Y9 1/20 0.36
▸ ASAH1 Q13510 1/20 0.36
▸ FFAR4 Q5NUL3 2/20 0.35
▸ LTA4H P09960 1/20 0.35
▸ EPHX2 P34913 1/20 0.35
▸ MAPK14 Q16539 1/20 0.35
▸ BCL2L1 Q07817 1/20 0.34
▸ MCL1 Q07820 1/20 0.34
▸ BAD Q92934 1/20 0.34
▸ PPARD Q03181 2/20 0.34
▸ PPARA Q07869 1/20 0.34
▸ HIF1A Q16665 1/20 0.34
▸ SCN5A Q14524 1/20 0.34
▸ SCN9A Q15858 1/20 0.34
▸ TACR2 P21452 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25956089 0.90 PDPK1 (0.40) NOD2NOD1TRPV1
SCHEMBL30544106 0.90 PDPK1 (0.40) NOD2NOD1TRPV1
SCHEMBL30544057 0.88 SCN9A (0.44) TRPV1SCN8ASCN10AFFAR4BCL2L1
SCHEMBL25952320 0.88 SCN9A (0.44) TRPV1SCN8ASCN10AFFAR4BCL2L1
SCHEMBL30544026 0.86 TRPV1 (0.39) TRPV1SCN8ASCN10ASCN5ASCN9A
SCHEMBL25428113 0.86 TRPV1 (0.39) TRPV1SCN8ASCN10ASCN5ASCN9A
SCHEMBL25429484 0.86 SCN8A (0.43) TRPV1SCN8ASCN10AFFAR4SCN5A
SCHEMBL25429756 0.84 ICMT (0.39) TRPV1SCN8ASCN10AFFAR4SCN5A
SCHEMBL30544045 0.84 ICMT (0.39) TRPV1SCN8ASCN10AFFAR4SCN5A
SCHEMBL25954187 0.80 GRIN2B (0.50) TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023146511-A1 COMPOUNDS AND METHODS OF USE THEREOF VIVACE THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
Send feedback